Compliance Rate
Compliance Rate
66.67%
Compliant submissions
2
Incompliant submissions
1
Total trials
3
My Organizations' Clinical Trials
Showing 400 of 1308 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/11/21
End: 01/13/22
Due: 01/13/23
Phase: N/A
Priority: Normal
Start: 06/13/23
End: 04/08/25
Due: 04/08/26
Phase: N/A
Priority: Normal
Start: 07/01/17
End: 06/18/18
Due: 06/18/19
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 09/30/11
Due: 09/30/12
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 06/30/04
End: 10/31/06
Due: 10/31/07
Phase: N/A
Priority: Normal
Start: 03/01/21
End: 11/30/22
Due: 11/30/23
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 07/20/18
End: 05/01/21
Due: 05/01/22
Phase: N/A
Priority: Normal
Start: 08/01/25
End: 03/01/29
Due: 03/01/30
Phase: N/A
Priority: Normal
Start: 04/30/07
End: 03/31/13
Due: 03/31/14
Phase: N/A
Priority: Normal
Start: 05/09/24
End: 12/30/25
Due: 12/30/26
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 11/30/01
End: 11/30/05
Due: 11/30/06
Phase: N/A
Priority: Normal
Start: 10/01/16
End: 05/15/22
Due: 05/15/23
Phase: N/A
Priority: Normal
Start: 10/01/20
End: 10/01/25
Due: 10/01/26
Phase: N/A
Priority: Normal
Start: 06/26/22
End: 10/15/23
Due: 10/15/24
Phase: N/A
Priority: Normal
Start: 02/10/21
End: 10/30/23
Due: 10/30/24
Phase: N/A
Priority: Normal
Start: 05/22/20
End: 12/20/26
Due: 12/20/27
Phase: N/A
Priority: Normal
Start: 05/01/12
End: 03/31/18
Due: 03/31/19
Phase: N/A
Priority: Normal
Start: 10/31/08
End: -
Due: -
Early DHA/ARA Supplementation in Growth-restricted Very Preterm Infants: A Randomized Clinical Trial
Phase: N/A
Priority: Normal
Start: 05/20/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 04/03/23
End: 08/27/24
Due: 08/27/25
Phase: N/A
Priority: Normal
Start: 04/30/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/05
End: 08/31/06
Due: 08/31/07